The randomised study of epicardial application of hydrogel with amiodarone for prevention of postoperative atrial fibrillation in patients after coronary artery bypass grafting

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Teimuraz Kanametov

A.N. Bakulev National Medical Research Centre of Cardiovascular Surgery, Moscow (Russian Federation)

4 More presentations in this session

Presentation thumbnail

Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on vein-graft patency 1 year after coronary artery bypass grafting with or without diabetes: a post-hoc analysis of the DACAB tria

Doctor Y. Zhu (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Preoperative dual antiplatelet therapy and early outcomes in patients undergoing coronary artery bypass grafting

Doctor J. Qu (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

"New-onset atrial fibrillation efter cardiac surgery is associated with increased long-term morbidity and mortality": a population-based study from the SWEDEHEART-registry.

Doctor A. Taha (Gothenburg, SE)

Abstract Slides Video

Presentation thumbnail

Limited impact of concomitant coronary artery by-pass grafting on long-term outcomes after surgical aortic valve replacement: a nationwide propensity matched study

Doctor V. Kyto (Turku, FI)

Abstract Slides Video

Access the full session

Session thumbnail

Factors affecting prognosis of CABG patients

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Ethanol ablation of left ventricular summit in a patient with repaired congenital heart disease: when the going gets though

Congress Session

Atrial fibrillation (1)

Congress Session

Supraventricular tachycardia (3)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources